Daunomycin IV injection 20mg, manufactured by Meiji Seika Pharma, contains Daunorubicin hydrochloride, an anthracycline antibiotic used in chemotherapy primarily for acute myeloid leukemia and acute lymphocytic leukemia. It has a YJ code of 4235401D1035 and a standard of 20mg 1 bottle.
Daunomycin IV injection 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →